3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
24
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Myelodysplastic Syndromes
15
Hodgkin Disease
13
Lymphoma, Non-Hodgkin
11
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma
8
Leukemia, Biphenotypic, Acute
8
Leukemia
8
Burkitt Lymphoma
7
Breast Neoplasms
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neuroblastoma
5
Neoplasms
5
Multiple Myeloma
5
Lymphoma, Mantle-Cell
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hematologic Neoplasms
5
Triple Negative Breast Neoplasms
4
Sarcoma
4
Rhabdomyosarcoma
4
Medulloblastoma
4
Lymphoma, Follicular
4
Anemia, Refractory, with Excess of Blasts
4
Leukemia, Myelomonocytic, Chronic
3
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell, Marginal Zone
2
Interventions
Echocardiography
6
Doxorubicin
3
Carvedilol
3
empagliflozin
2
Social Determinants of Health
2
High-Intensity Interval Training
2
Electrocardiography
2
Cyclophosphamide
2
pegfilgrastim
1
dapagliflozin
1
Watchful Waiting
1
Vincristine
1
Vascular Stiffness
1
Trastuzumab
1
Tablets
1
Standard of Care
1
Rosuvastatin Calcium
1
Rituximab
1
Resistance Training
1
Pulse Wave Analysis
1
Prednisolone
1
Palliative Care
1
Observation
1
Methods
1
Lenalidomide
1
Hematologic Tests
1
Fenofibrate
1
Exercise Test
1
Exercise
1
Environmental Biomarkers
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Filgrastim
×
1 year
×
Clear all
No trials found.